Welcome to our dedicated page for Carmell Corporation Warrant news (Ticker: CTCXW), a resource for investors and traders seeking the latest updates and insights on Carmell Corporation Warrant stock.
The CTCXW news page on Stock Titan provides historical news coverage related to the redeemable warrants that were originally issued by Carmell Corporation, a company described in its own communications as a bio-aesthetics business. In a corporate announcement, Carmell Corporation explained that it changed its name to Longevity Health Holdings, Inc. and that its common stock and redeemable warrants began trading under the symbols XAGE and XAGEW, respectively.
News items linked to the historical CTCXW symbol can include corporate updates about rebranding, strategic direction, and acquisitions connected to the company behind the warrants. The rebranding announcement highlights a business focus on longevity and healthy aging, as well as a growth strategy that includes acquisitions and strategic partnerships alongside organic development of existing operations.
One notable development described in the company’s communication is the acquisition of Elevai Skincare, Inc., which the company states delivered a commercial product pipeline based on stem cell exosome technology. The same announcement references the company’s allogeneic PRP Secretome technology in regenerative bio-aesthetics, providing additional context for news about its technology base and product pipeline.
Investors and researchers reviewing the CTCXW news archive can use this page to understand how the warrants were tied to Carmell Corporation prior to its rebranding as Longevity Health Holdings, Inc., and how subsequent updates refer to the new symbols XAGE and XAGEW. For ongoing developments, users can look for news that references the updated corporate name and trading symbols while using this archive for background and historical perspective.
Carmell (NASDAQ: CTCX) announced a corporate rebranding to Longevity Health Holdings, with new trading symbols XAGE and XAGEW effective March 10, 2025. The rebranding reflects the company's expanded focus on longevity and healthy aging, including bio-aesthetics, diagnostics, and nutrition.
Following the January 2025 acquisition of Elevai Skincare, combined sales grew 34% in the first two months of 2025 compared to 2024. The company reduced Elevai's burn rate by 50% through overhead cost savings, while doubling the physician-focused salesforce. FY25 revenue guidance is projected at $3-4 million from current products.
The company plans to launch four new products in Q2 2025: Hair Growth Serum, Soapless Facial Cleanser, Undereye Crème, and VSA Toning Moisturizer. Additionally, Patrick Sturgeon, a founding team member and former CFO, has been appointed as Vice Chairman.